Dugel Pravin sold 21,156 shares of OCULAR THERAPEUTIX, INC at $8.20 for −$173k on May 26, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
See Remarks
See Remarks
Filed May 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$173,479.20Shares × reported price
Shares traded
21,156Common Stock
Price per share
$8.20Reported price. Read footnotes for ranges.
% of reported position traded
0.81%This security and ownership context
Holdings after
2,597,170Direct
Trade date
May 26, 2026Sell
Filed
May 28, 2026, 4:08 PM ET2-day reporting delay
Accession
0001104659-26-067485Code S · Transaction 387128
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,618,326 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 28, 2026Gift394,696$0.00$0Trade 387130
May 28, 2026Gift394,696$0.00$0Trade 387129
3 transaction rows in this filing. Joint filers share the same rows.

OCUL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OCUL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.7%1w ago −13%1d ago −10%
Returns since7d −3.8%30d +7.5%90d +18%180d1y

Footnotes in full

F1: Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1450 to $8.2521, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. F3: On May 28, 2026, the reporting person's spouse transferred 394,696 shares to the Pravin Dugel 2024 Irrevocable Trust (the "Trust") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust.